Celiac Disease Foundation Impact Fund

vc$15MCo-invests

◆ Fund Size

$15M

◆ Location

United States

◆ Activity

Statusactively investing

◆ Links

Website ↗@celiacdotorg on X ↗

◆ Investment Thesis

A venture philanthropy fund designed to accelerate innovation across the celiac disease ecosystem by investing in early detection, prevention, education, and curative breakthroughs.

◆ About Celiac Disease Foundation

The Celiac Disease Foundation Impact Fund is a mission-driven venture philanthropy fund focused on companies that can accelerate detection, prevention, education, and treatment of celiac disease. It uses catalytic capital alongside venture-style diligence to support scalable innovations across diagnostics, biomarkers, microbiome and immune-modulating therapies, education tools, and potential cures.

◆ Sectors

BiotechDiagnosticsDigital HealthDrug DiscoveryMedtech

◆ Stages

seedseries-a

◆ Geography Focus

worldwide

◆ Team

Name	Title	Role	Links
Brett Spitale	Chief Advancement Officer	senior	in 𝕏
Gregg Stein	founding partner	senior	in 𝕏
Marilyn Geller	chief executive officer	—	in 𝕏
Triple G Ventures	Investment manager / partner	—
Triple G Ventures team	Investment manager	senior

◆ Traits

Co-invests

◆ FAQ

What does Celiac Disease Foundation Impact Fund invest in?

Celiac Disease Foundation Impact Fund invests in Biotech, Diagnostics, Digital Health, Drug Discovery and Medtech at the seed and series-a stages.

Which geographies does Celiac Disease Foundation Impact Fund focus on?

Celiac Disease Foundation Impact Fund focuses on worldwide, and is headquartered in United States.